Mangubat, Nancy Mae .
HRN: 25-38-69 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/18/2025
AMPICILLIN 500MG (VIAL)
11/18/2025
11/24/2025
IV
370mg
Q6
URTI
Checking Final Appropriateness
Indication: Empiric Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes